These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37375205)

  • 21. Trypanocidal Activity of Flavokawin B, a Component of Polygonum ferrugineum Wedd.
    Rodrigues DF; Maniscalco DA; Silva FA; Chiari BG; Castelli MV; Isaac VL; Cicarelli RM; López SN
    Planta Med; 2017 Feb; 83(3-04):239-244. PubMed ID: 27442262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coumaro-chalcones synthesized under solvent-free conditions as potential agents against malaria, leishmania and trypanosomiasis.
    Cuellar JE; Quiñones W; Robledo S; Gil J; Durango D
    Heliyon; 2022 Feb; 8(2):e08939. PubMed ID: 35198789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis, Leishmanicidal, Trypanocidal, Antiproliferative Assay and Apoptotic Induction of (2-Phenoxypyridin-3-yl)naphthalene-1(2
    Blanco Z; Fernandez-Moreira E; Mijares MR; Celis C; Martínez G; De Sanctis JB; Gurská S; Džubák P; Hajdůch M; Mijoba A; García Y; Serrano X; Herrera N; Correa-Abril J; Parra Y; Ángel J; Ramírez H; Charris JE
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The antileishmanial activity of novel oxygenated chalcones and their mechanism of action.
    Zhai L; Chen M; Blom J; Theander TG; Christensen SB; Kharazmi A
    J Antimicrob Chemother; 1999 Jun; 43(6):793-803. PubMed ID: 10404318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel prenyloxy chalcones as potential leishmanicidal and trypanocidal agents: Design, synthesis and evaluation.
    Espinoza-Hicks JC; Chacón-Vargas KF; Hernández-Rivera JL; Nogueda-Torres B; Tamariz J; Sánchez-Torres LE; Camacho-Dávila A
    Eur J Med Chem; 2019 Apr; 167():402-413. PubMed ID: 30784876
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biphenylquinuclidines as inhibitors of squalene synthase and growth of parasitic protozoa.
    Orenes Lorente S; Gómez R; Jiménez C; Cammerer S; Yardley V; de Luca-Fradley K; Croft SL; Ruiz Perez LM; Urbina J; Gonzalez Pacanowska D; Gilbert IH
    Bioorg Med Chem; 2005 May; 13(10):3519-29. PubMed ID: 15848765
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting the polyamine biosynthetic enzymes: a promising approach to therapy of African sleeping sickness, Chagas' disease, and leishmaniasis.
    Heby O; Persson L; Rentala M
    Amino Acids; 2007 Aug; 33(2):359-66. PubMed ID: 17610127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: a review of recent articles.
    Nweze JA; Mbaoji FN; Li YM; Yang LY; Huang SS; Chigor VN; Eze EA; Pan LX; Zhang T; Yang DF
    Infect Dis Poverty; 2021 Jan; 10(1):9. PubMed ID: 33482912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Herbicides to curb human parasitic infections: in vitro and in vivo effects of trifluralin on the trypanosomatid protozoans.
    Chan MM; Grogl M; Chen CC; Bienen EJ; Fong D
    Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5657-61. PubMed ID: 8516314
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of Novel Chalcone-Thiosemicarbazones Derivatives as Potential Anti-
    Mendes EP; Goulart CM; Chaves OA; Faiões VDS; Canto-Carvalho MM; Machado GC; Torres-Santos EC; Echevarria A
    Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31652866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naphthoquinones and Derivatives for Chemotherapy: Perspectives and Limitations of their Anti-trypanosomatids Activities.
    Dantas-Pereira L; Cunha-Junior EF; Andrade-Neto VV; Bower JF; Jardim GAM; da Silva Júnior EN; Torres-Santos EC; Menna-Barreto RFS
    Curr Pharm Des; 2021; 27(15):1807-1824. PubMed ID: 33167829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comprehensive review of chalcone derivatives as antileishmanial agents.
    de Mello MVP; Abrahim-Vieira BA; Domingos TFS; de Jesus JB; de Sousa ACC; Rodrigues CR; Souza AMT
    Eur J Med Chem; 2018 Apr; 150():920-929. PubMed ID: 29602038
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
    Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
    Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Broad Spectrum and Safety of Oral Treatment with a Promising Nitrosylated Chalcone in Murine Leishmaniasis.
    Sousa-Batista AJ; Escrivani-Oliveira D; Falcão CAB; Philipon CIMDS; Rossi-Bergmann B
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting chalcone binding sites in living Leishmania using a reversible fluorogenic benzochalcone probe.
    Batista AS; Oliveira SDS; Pomel S; Commere PH; Mazan V; Lee M; Loiseau PM; Rossi-Bergmann B; Prina E; Duval R
    Biomed Pharmacother; 2022 May; 149():112784. PubMed ID: 35299122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Conventional therapy and promising plant-derived compounds against trypanosomatid parasites.
    Alviano DS; Barreto AL; Dias Fde A; Rodrigues Ide A; Rosa Mdo S; Alviano CS; Soares RM
    Front Microbiol; 2012; 3():283. PubMed ID: 22888328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Carbohydrate-naphthalene diimide conjugates as potential antiparasitic drugs: Synthesis, evaluation and structure-activity studies.
    Zuffo M; Stucchi A; Campos-Salinas J; Cabello-Donayre M; Martínez-García M; Belmonte-Reche E; Pérez-Victoria JM; Mergny JL; Freccero M; Morales JC; Doria F
    Eur J Med Chem; 2019 Feb; 163():54-66. PubMed ID: 30503943
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chalcones identify cTXNPx as a potential antileishmanial drug target.
    Escrivani DO; Charlton RL; Caruso MB; Burle-Caldas GA; Borsodi MPG; Zingali RB; Arruda-Costa N; Palmeira-Mello MV; de Jesus JB; Souza AMT; Abrahim-Vieira B; Freitag-Pohl S; Pohl E; Denny PW; Rossi-Bergmann B; Steel PG
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009951. PubMed ID: 34780470
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inefficacy of metronidazole in experimental infections of Leishmania donovani, L. mexicana, and Trypanosoma brucei brucei.
    Keithly JS; Langreth SG
    Am J Trop Med Hyg; 1983 May; 32(3):485-96. PubMed ID: 6305218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of novel prenylated chalcone derivatives as anti-leishmanial and anti-trypanosomal compounds.
    Passalacqua TG; Dutra LA; de Almeida L; Velásquez AM; Torres FA; Yamasaki PR; dos Santos MB; Regasini LO; Michels PA; Bolzani Vda S; Graminha MA
    Bioorg Med Chem Lett; 2015 Aug; 25(16):3342-5. PubMed ID: 26055530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.